HMGB-1, a DNA-binding protein with cytokine activity, induces brain TNF and IL-6 production, and mediates anorexia and taste aversion

被引:129
作者
Agnello, D
Wang, HC
Yang, H
Tracey, KJ
Ghezzi, P
机构
[1] Mario Negri Inst Pharmacol Res, Lab Neuroimmunol, I-20157 Milan, Italy
[2] N Shore Univ Hosp, Lab Biomed Sci, Manhasset, NY USA
关键词
D O I
10.1006/cyto.2002.0890
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
High-mobility group protein-1 (HMG-1 also termed HMGB-1), a DNA-binding protein, regulates gene transcription and stabilizes nucleosome formation. HMG-1 was recently implicated as a cytokine, because it is a late-acting mediator of endotoxin lethality that induces the release of pro-inflammatory cytokines from monocytes. Here it is shown that administration of HMG-1 into the cerebral ventricles decreases food intake (food intake=4.6 g/mouse in controls vs 1.6 g/mouse after 1 mug HMG-1 i.c.v.; P<0.05). Intracerebroventricular HNIG-1 induced an increased in TNF and IL-6 expression in the brain, and mediated taste aversion with potencies equivalent to LIPS. In a model of endotoxemia, passive immunization with anti-HMG-1 antibodies attenuated the development of hypophagia, indicating that HMG-1 is a mediator of sickness behaviour associated with endotoxemia. (C) 2002 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:231 / 236
页数:6
相关论文
共 15 条
[1]  
AGGARWAL BB, 1985, J BIOL CHEM, V260, P2345
[2]   High mobility group 1 protein (HMG-1) stimulates proinflammatory cytokine synthesis in human monocytes [J].
Andersson, U ;
Wang, HC ;
Palmblad, K ;
Aveberger, AC ;
Bloom, O ;
Erlandsson-Harris, H ;
Janson, A ;
Kokkola, R ;
Zhang, MH ;
Yang, H ;
Tracey, KJ .
JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 192 (04) :565-570
[3]   LIMITED IMPORTANCE OF A LEARNED AVERSION IN THE HYPOPHAGIC EFFECT OF INTERLEUKIN-1-BETA [J].
BAUER, C ;
WEINGARTEN, S ;
SENN, M ;
LANGHANS, W .
PHYSIOLOGY & BEHAVIOR, 1995, 57 (06) :1145-1153
[4]   Molecular basis of sickness behavior [J].
Dantzer, R ;
Bluthé, RM ;
Gheusi, G ;
Cremona, S ;
Layé, S ;
Parnet, P ;
Kelley, KW .
MOLECULAR MECHANISMS OF FEVER, 1998, 856 :132-138
[5]   Cytokines and sickness behavior [J].
Dantzer, R ;
Bluthé, RM ;
Layé, S ;
Bret-Dibat, JL ;
Parnet, P ;
Kelley, KW .
NEUROIMMUNOMODULATION: MOLECULAR ASPECTS, INTEGRATIVE SYSTEMS, AND CLINICAL ADVANCES, 1998, 840 :586-590
[6]   PHARMACOLOGICAL EFFECTS PRODUCED BY INTRACEREBRAL INJECTION OF DRUGS IN THE CONSCIOUS MOUSE [J].
HALEY, TJ ;
MCCORMICK, WG .
BRITISH JOURNAL OF PHARMACOLOGY AND CHEMOTHERAPY, 1957, 12 (01) :12-15
[7]   SICKNESS BEHAVIOR AS A NEW TARGET FOR DRUG DEVELOPMENT [J].
KENT, S ;
BLUTHE, RM ;
KELLEY, KW ;
DANTZER, R .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1992, 13 (01) :24-28
[8]   CENTRAL ADMINISTRATION OF THE PEPTIDE ALPHA-MSH INHIBITS INFLAMMATION IN THE SKIN [J].
LIPTON, JM ;
MACALUSO, A ;
HILTZ, ME ;
CATANIA, A .
PEPTIDES, 1991, 12 (04) :795-798
[9]  
MERENMIES J, 1991, J BIOL CHEM, V266, P16722
[10]  
RAUVALA H, 1987, J BIOL CHEM, V262, P16625